Related Experiment Video
Updated: Jun 29, 2025
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Can platelet activation markers predict preeclampsia and/or its severity?
Tuğçe Arslanoğlu1, Kübra Kurt-Bilirer1, Nihal Çallıoğlu1
1Clinic of Perinatology.
Insights
Platelet activation markers, specifically PDW and MPV, show promise in diagnosing and monitoring preeclampsia. However, these markers are not yet sufficient for predicting the severity of preeclampsia.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Perinatal Medicine
Background:
- Preeclampsia is a serious pregnancy complication affecting 3-5% of pregnancies.
- It poses significant risks of morbidity and mortality to both mother and fetus.
- Accurate prediction and diagnosis are crucial for effective management.
Purpose of the Study:
- To assess the utility of platelet activation markers in predicting preeclampsia.
- To evaluate the role of these markers in determining preeclampsia severity.
- To explore potential improvements in preeclampsia management strategies.
Main Methods:
- Included 99 preeclampsia patients and 60 healthy pregnant controls.
- Evaluated platelet activation markers: mean platelet volume (MPV), platelet distribution width (PDW), platelet count, and plateletcrit.
- Assessed clinical parameters alongside platelet markers.
Main Results:
- Platelet activation markers, particularly PDW and MPV, demonstrated value in diagnosing and following preeclampsia.
- These markers were found insufficient for predicting the severity of preeclampsia.
- Further investigation is warranted for their predictive role in disease severity.
Conclusions:
- Platelet activation markers may assist in predicting, diagnosing, and managing preeclampsia.
- Additional research is necessary to establish their role in predicting preeclampsia severity.
- Findings could inform better prevention and management strategies, improving maternal and fetal outcomes.
Objective:
This study aimed to evaluate the value of platelet activation markers in predicting preeclampsia and its severity. Preeclampsia is a serious pregnancy complication that affects 3-5% of pregnancies and can lead to significant morbidity and mortality for both the mother and the fetus.
Methods:
The study included 99 patients diagnosed with preeclampsia and 60 healthy pregnant women as a control group. Platelet activation markers such as mean platelet volume (MPV), platelet distribution width (PDW), platelet count, and plateletcrit were evaluated along with other clinical parameters.
Results:
The results of the study showed that platelet activation markers, particularly PDW and MPV, are valuable in the diagnosis and follow-up of preeclampsia. However, they are not sufficient to predict the severity of the disease.
Conclusion:
The study suggests that platelet activation markers could aid in predicting, diagnosing, and managing preeclampsia. However, further research is needed to determine the role of these markers in predicting the severity of the disease. The findings of this study could contribute to the development of more effective strategies for the prevention and management of preeclampsia, which could ultimately improve maternal and fetal outcomes.
More Related Videos
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...